Recently, reduced expression of the BRCA1 and PTEN tumor suppressors have been implicated in the synaptic deficits observed in AD66, 67, contributing to an emerging hypothesis that tumor suppressor dysfunction underlies AD pathophysiology. The gene discussed is BRCA1; the disease is Alzheimer disease.